 - Hematologic malignancies Those with high risk or relapsed hematologic malignancy including myeloid and lymphoid leukemias and lymphomas, myeloma or myelomatous like diseases, myeloproliferative disease, myelodysplasia. Those with good risk disease first remission acute myeloid leukemia AML with myelomonocytic together with bone marrow eosinophilia M4eos - inversions in chromosome 16, promyelocytic M3 AML with translocations in chromosomes 15;17; or translocations in chromosomes 8;21 in first remission are not eligible. 